| 1 |
Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer
Gabig TG, Waltzer WC, Whyard T, Romanov V
Biochemical and Biophysical Research Communications, 478(2), 887, 2016 |
| 2 |
Claudins Overexpression in Ovarian Cancer: Potential Targets for Clostridium Perfringens Enterotoxin (CPE) Based Diagnosis and Therapy
English DP, Santin AD
International Journal of Molecular Sciences, 14(5), 10412, 2013 |
| 3 |
Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder
Matsuhisa K, Kondoh M, Suzuki H, Yagi K
Biochemical and Biophysical Research Communications, 423(2), 229, 2012 |
| 4 |
Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro
Takahashi A, Kondoh M, Uchida H, Kakamu Y, Hamakubo T, Yagi K
Biochemical and Biophysical Research Communications, 410(3), 466, 2011 |
| 5 |
Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers
Yao Q, Cao SY, Li C, Mengesha A, Low P, Kong BH, Dai SZ, Wei MQ
Biochemical and Biophysical Research Communications, 398(3), 413, 2010 |
